Institutional investors hold a majority ownership of PDLI through the 85.11% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $30.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GLOBAL X MANAGEMENT CO. LLC Bought 195.5 Thousand shares of PDL BioPharma Inc
CIBC WORLD MARKETS, INC. Bought 63.9 Thousand shares of PDL BioPharma Inc
LIFESCI INDEX PARTNERS LLC Bought 26.5 Thousand shares of PDL BioPharma Inc